Harnessing the Power of Natural Products for Targeted Protein Degradation

被引：0
作者：
Zhu, Bo [1 ]
Wu, Zheng [2 ,3 ]
Shou, Yiwen [2 ,3 ]
Zhao, Kaili [2 ,3 ]
Lu, Qinpei [2 ,3 ]
Qin, Jiang-Jiang [4 ]
Guo, Hongwei [2 ,3 ]
机构：
[1] Guangxi Med Univ, Collaborat Innovat Ctr Regenerat Med & Med BioReso, Nanning, Guangxi, Peoples R China
[2] Guangxi Med Univ, Key Lab Longev & Aging Related Dis Chinese, Guangxi Key Lab Bioact Mol Res & Evaluat, Minist Educ, Nanning, Guangxi, Peoples R China
[3] Guangxi Med Univ, Coll Pharm, Nanning, Guangxi, Peoples R China
[4] Chinese Acad Sci, Hangzhou Inst Med HIM, Ctr Innovat Drug Res, Hangzhou, Zhejiang, Peoples R China
来源：
MEDICINAL RESEARCH REVIEWS | 2025年
基金：
中国国家自然科学基金;
关键词：
computer-aided technology; natural products; PROTACs; targeted protein degradation; E3 UBIQUITIN LIGASE; PSEUDOLARIC ACID-B; SMALL MOLECULES; IN-VITRO; AMINOPEPTIDASE-B; OLEANOLIC ACID; URSOLIC ACID; PROTACS; INHIBITORS; RECEPTOR;
D O I：
10.1002/med.22113
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Natural products have garnered significant attention due to their complex chemical structures and remarkable pharmacological activities. With inherent recognition capabilities for protein surfaces, natural products serve as ideal candidates for designing proteolysis-targeting chimeras (PROTACs). The utilization of natural products in PROTAC development offers distinct advantages, including their rich chemical diversity, multitarget activities, and sustainable sourcing. This comprehensive review explores the vast potential of harnessing natural products in PROTAC research. Moreover, the review discusses the application of natural degradant technology, which involves utilizing natural product-based compounds to selectively degrade disease-causing proteins, as well as the implementation of computer-aided drug design (CADD) technology in identifying suitable targets for degradation within the realm of natural products. By harnessing the power of natural products and leveraging computational tools, PROTACs derived from natural products have the potential to revolutionize drug discovery and provide innovative therapeutic interventions for various diseases.
引用
收藏
页数：49
相关论文
共 235 条
[1]   Identification of suitable target/E3 ligase pairs for PROTAC development using a rapamycin-induced proximity assay (RiPA) [J].
Adhikari, Bikash ;
Schneider, Katharina ;
Diebold, Mathias ;
Sotriffer, Christoph ;
Wolf, Elmar .
ELIFE, 2024, 13
[2]   Design of Chemically Stable, Potent, and Efficacious MDM2 Inhibitors That Exploit the Retro-Mannich Ring-Opening-Cyclization Reaction Mechanism in Spiro-oxindoles [J].
Aguilar, Angelo ;
Sun, Wei ;
Liu, Liu ;
Lu, Jianfeng ;
McEachern, Donna ;
Bernard, Denzil ;
Deschamps, Jeffrey R. ;
Wang, Shaomeng .
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (24) :10486-10498
[3]   Therapeutic Potential of Ursolic Acid in Cancer and Diabetic Neuropathy Diseases [J].
Alam, Manzar ;
Ali, Sabeeha ;
Ahmed, Sarfraz ;
Elasbali, Abdelbaset Mohamed ;
Adnan, Mohd ;
Islam, Asimul ;
Hassan, Md Imtaiyaz ;
Yadav, Dharmendra Kumar .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (22)
[4]   Natural products can be used in therapeutic management of COVID-19: Probable mechanistic insights [J].
Ali, Sabeeha ;
Alam, Manzar ;
Khatoon, Fatima ;
Fatima, Urooj ;
Elasbali, Abdelbaset Mohamed ;
Adnan, Mohd ;
Islam, Asimul ;
Hassan, Md. Imtaiyaz ;
Snoussi, Mejdi ;
De Feo, Vincenzo .
BIOMEDICINE & PHARMACOTHERAPY, 2022, 147
[5]   Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies [J].
Allegra, Alessandro ;
Innao, Vanessa ;
Russo, Sabina ;
Gerace, Demetrio ;
Alonci, Andrea ;
Musolino, Caterina .
CANCER INVESTIGATION, 2017, 35 (01) :1-22
[6]   Cortistatins A, B, C, and D, anti-angiogenic steroidal alkaloids, from the marine sponge Corticium simplex [J].
Aoki, S ;
Watanabe, Y ;
Sanagawa, M ;
Setiawan, A ;
Kotoku, N ;
Kobayashi, M .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2006, 128 (10) :3148-3149
[7]   A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo [J].
Bai, Longchuan ;
Zhou, Haibin ;
Xu, Renqi ;
Zhao, Yujun ;
Chinnaswamy, Krishnapriya ;
McEachern, Donna ;
Chen, Jianyong ;
Yang, Chao-Yie ;
Liu, Zhaomin ;
Wang, Mi ;
Liu, Liu ;
Jiang, Hui ;
Wen, Bo ;
Kumar, Praveen ;
Meagher, Jennifer L. ;
Sun, Duxin ;
Stuckey, Jeanne A. ;
Wang, Shaomeng .
CANCER CELL, 2019, 36 (05) :498-+
[8]   Targeted Degradation of BET Proteins in Triple-Negative Breast Cancer [J].
Bai, Longchuan ;
Zhou, Bing ;
Yang, Chao-Yie ;
Ji, Jiao ;
McEachern, Donna ;
Przybranowski, Sally ;
Jiang, Hui ;
Hu, Jiantao ;
Xu, Fuming ;
Zhao, Yujun ;
Liu, Liu ;
Fernandez-Salas, Ester ;
Xu, Jing ;
Dou, Yali ;
Wen, Bo ;
Sun, Duxin ;
Meagher, Jennifer ;
Stuckey, Jeanne ;
Hayes, Daniel F. ;
Li, Shunqiang ;
Ellis, Matthew J. ;
Wang, Shaomeng .
CANCER RESEARCH, 2017, 77 (09) :2476-2487
[9]   The Molecular Mechanisms Regulating the KEAP1-NRF2 Pathway [J].
Baird, Liam ;
Yamamoto, Masayuki .
MOLECULAR AND CELLULAR BIOLOGY, 2020, 40 (13)
[10]   Ancient drug curcumin impedes 26S proteasome activity by direct inhibition of dual-specificity tyrosine-regulated kinase 2 [J].
Banerjee, Sourav ;
Ji, Chenggong ;
Mayfield, Joshua E. ;
Goel, Apollina ;
Xiao, Junyu ;
Dixon, Jack E. ;
Guo, Xing .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (32) :8155-8160
12345678910